At the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California, Melinda Gooderham, MSc, MD, FRCPC, presented late-breaking data on the long-term safety and efficacy of delgocitinib for moderate to severe chronic hand eczema (CHE).1 Patients who completed 16 weeks of treatment in DELTA 1 and DELTA 2 were then treated in […]
Georgia woman battles chronic pain after using steroid cream 11Alive.com WXIA Source link
Chronic Hand Eczema Market to Accelerate Substantially During the … Digital Journal Source link